Newsletter Insights — advertising rates and audience data for 33K+ newsletters
Browse all →Track Lusso's News Insider's growth
Get notified when subscribers, engagement, or pricing changes
Platform Portability
Uses Substack subdomain (powerhouse.substack.com). Migrating would require subscribers to re-subscribe at a new address.
Custom domains let newsletters switch platforms without losing their audience.
Are you a newsletter creator? Get verified insights →
Written by a Wall Street veteran with over 120,000 subscribers, this newsletter provides in-depth analysis and commentary on the latest market trends and stock picks. This is a Substack Bestselling publication.
Data updated Today
1.6K paid
Weekly Growth
+5.3%
Paid Subscriber Retention
+9.8%
net growth
Track revenue changes over time
Start tracking — freeTrack CPM rates as they change
Start tracking — freeSubscriber counts are rounded by the platform — step changes may not reflect actual growth
Avg Likes
12.1
Engagement Rate
0.02%· ~12 likes + comments/post
(comments + likes) / subscribers
Quality Score
Engagement vs Finance
0.02% engagement rate
Score Breakdown
Engagement Score
vs 264 newsletters in Finance
56K places you in the top 10% of newsletters in this category.
Engagement Rate
0.02%
median: 0.00%
Posts per Week
0.8
median: 1.1
Publishing Consistency
0/100
median: 67/100
Subscribers
56K
median: 2K
| Public |
| RE: Cardiol Therapeutics (NASDAQ: CRDL) is officially our Godzilla Stock PickPut $CRDL on Your Watchlist For DDMay 27, 2026 | Public |
| Our Godzilla Stock Pick is now LIVE!Is This Stock The Next Big Story?May 26, 2026 | Public |
| 24 Hours Until Godzilla Stock Alert; Claim 2nd Hint Now2nd Hint For Godzilla Stock Pick UnleashedMay 26, 2026 | Subscriber-only |
| 🚨 ALERT: The Ceasefire Pivot & Our Tuesday GameplanWhy we are dumping our energy hedges.May 23, 2026 | Public |
| The Tuesday Stock Market Setup: Rotation, Not Crash — Where The Money Is Actually GoingStock Chart Alerts Pro — VIP High Net Worth Trading ProgramMay 19, 2026 | Subscriber-only |
| CRDL: $1.29 → $1.39 in under a weekCardiol Therapeutics (NASDAQ: CRDL) is up 7.75% since our alert — here's why I'm still focused on this name.May 14, 2026 | Public |
| The Hunt for the Next 5-Bagger: Deep Dive on 10 Asymmetric PlaysFinding the next 5 bagger !May 11, 2026 | Subscriber-only |
| Stock Alerts Pro — Issue 001: Cardiol Therapeutics (NASDAQ: CRDL)NASDAQ: CRDL Is Our First FeatureMay 8, 2026 | Public |
Hump 🐪 Days
73K subs
Graham’s Newsletter
39K subs
Epic Retirement Australia & New Zealand
89K subs
Get email alerts when subscribers drop or spike, when new sponsors appear, when pricing changes, or when publishing cadence shifts. Track unlimited newsletters across your watchlist with the Starter plan.
$29/mo·cancel anytime
See what's includedGet the full whitespace list with each brand's category fit, audience overlap, and recommended pitch order. Plus a comparison of Lusso's News Insider vs the top 15 peer newsletters on sponsor mix, growth, and CPM.
Including Tegus, HubSpot, Stream + 50 more.
$300·2-3 working days·refunded if we can't deliver
Publishing Frequency
~2x per week
Last published May 28, 2026
0.8 posts/week avg
Finance Pricing
$12/mo median
Premium tier
Monetization Readiness
Already monetizing
100% of similar-size Finance newsletters also have paid tiers
Unlock revenue estimates, CPM benchmarks, and detected sponsors
Start tracking — freeConsistency Below Category Median
Publishing consistency (0/100) is below the Finance median (67/100).